Cataract Surgery Postoperative Care

Cataract extraction with intraocular lens implantation is one of the most frequently performed elective surgical procedures, and most patients are discharged the same day to be followed by their surgeon at scheduled visits while day-to-day questions and a complex postoperative drop regimen fall to a community pharmacist or primary care practitioner in between.^[1] The postoperative period centers on 3 pharmacologic goals: prevent infection (bacterial endophthalmitis), control inflammation and prevent cystoid macular edema (CME), and support comfort and healing while the eye recovers. Achieving this typically means a multi-week regimen of a topical antibiotic, a topical corticosteroid on a defined taper, and often a topical NSAID — 3 different bottles, 3 different schedules, and sometimes 3 different tapering timelines in the same patient. Without a slit lamp, tonometer, or indirect ophthalmoscope, a community pharmacist or primary care practitioner cannot definitively diagnose a postoperative complication; the role in this setting is early recognition of red flags that need urgent ophthalmology referral, plus adherence support for a regimen that is genuinely easy to get wrong.

The expected normal postoperative course

A comfortable eye is the expectation after cataract surgery — at worst, a mild foreign-body sensation is normal. Postoperative inflammation from the surgery itself is most prominent in the first 48 hours, while infection (endophthalmitis) most commonly develops between days 3 and 7, though it can occur at any point afterward.

Some findings are expected and, on their own, do not indicate a problem: transient blurred vision right after instilling a drop, mild grittiness, and dysphotopsia — glare or a shadow in the peripheral vision from the edge of the intraocular lens — which is common in the first days to weeks after implantation and typically settles as the brain adapts. Confrontation visual field testing (finger counting in the periphery) should be normal in a patient with dysphotopsia; if it is not, or the shadow is progressive rather than stable, this is no longer routine dysphotopsia and needs assessment. A pinhole used to retest visual acuity can separate a genuine reduction in vision from an uncorrected refractive error.

Itching as the predominant symptom points toward an allergic reaction to one of the topical medications, or dry eye, rather than infection or inflammation, and it usually resolves with a change in drop formulation rather than a referral.

Risk factors for postoperative endophthalmitis

• Posterior capsule rupture or vitreous loss during surgery.
• Prolonged or complicated surgical time.
• Clear corneal incision technique, compared with a scleral tunnel incision.
• Diabetes mellitus or other immunosuppression.
• Pre-existing blepharitis or lid margin disease.
• Inadequate perioperative reduction of eyelid and periocular skin flora.
• Silicone oil use or a combined intraocular procedure.
• A postoperative wound leak.

Risk factors for cystoid macular edema

• Diabetic retinopathy.
• A personal history of uveitis, or CME in the fellow eye.
• Epiretinal membrane or other pre-existing macular pathology.
• Complicated surgery — posterior capsule rupture or vitreous loss.
• Concurrent use of a topical prostaglandin analogue for glaucoma.
• Poor adherence to the prescribed topical NSAID/corticosteroid course.

Risk factors for a postoperative intraocular pressure spike

• Pre-existing glaucoma or ocular hypertension.
• Pseudoexfoliation syndrome.
• Retained viscoelastic material at the end of surgery.
• A known steroid responder — a prior significant IOP rise with corticosteroid use.
• Complex surgery involving a small pupil or iris manipulation.

Differentiating causes of a postoperative concern

Several distinct problems can all present as "the eye doesn't feel right" after cataract surgery — telling them apart, or recognizing that this cannot be done without a slit lamp and tonometer, is the central assessment skill in this setting.

History

• Characterize the pain — the postoperative eye should be comfortable, at worst a mild foreign-body sensation; more intense pain suggests elevated IOP, increased inflammation, or infection.
• Ask about any trauma to the eye since surgery, which needs reassessment with a slit lamp regardless of how minor it seems.
• Ask about a change in vision — worsening, darkening, loss of detail, or peripheral visual loss — any significant change could indicate infection, hemorrhage, retinal detachment, or other acute intraocular pathology.
• Ask about visual phenomena — flashing lights, dark shadows, or floaters. Worsening floaters need reassessment to rule out infection, retinal tear/detachment, or uveitis; new, mild dysphotopsia (glare or a peripheral shadow) in the early weeks after lens implantation is usually not concerning provided confrontation visual fields are normal.
• Ask specifically about itching as the predominant symptom, which suggests an allergic reaction to a topical medication or dry eye rather than infection.
• Review the ocular medication regimen in detail — reinforce correct technique, clarify any confusion about which drop is which, and involve a family member if the patient is having trouble managing multiple bottles.
• Confirm the patient has a scheduled follow-up visit with the surgeon and knows when it is.

Examination — requires ophthalmology-level equipment

A visual acuity chart, slit lamp, tonometer, and indirect ophthalmoscope are needed to properly examine a postoperative cataract patient; a community pharmacist or primary care practitioner without these tools cannot reliably rule out the differentials above and should not attempt to. When these tools are available, key findings include: lid or conjunctival swelling (suggests drug allergy or infection); pupil reactivity, which should be normal unless a mydriatic was used; photophobia, which can indicate anterior uveitis or corneal haze from infection, inflammation, or elevated IOP; corneal clarity, which should be free of clouding or infiltrates; and a clear red reflex on ophthalmoscopy, whose absence suggests vitreous clouding, inflammation, or infection.

When testing is not indicated

A patient with mild, improving symptoms and no red flags does not need urgent same-day ophthalmology assessment — reassurance, a review of correct drop technique, and confirmation of the scheduled follow-up visit is appropriate. Any red flag from the callout above bypasses this and goes straight to urgent referral rather than a watch-and-wait approach, since the tools needed to safely rule out infection or a retinal problem are not available outside an eye care setting.

• Control inflammation.
• Prevent infection (endophthalmitis).
• Maintain eye comfort.
• Promote early visual rehabilitation.
• Detect intraocular infection at its earliest stage.
• Detect postoperative uveitis or intraocular pressure elevation early.
• Detect other abnormalities in the postoperative course — retinal detachment, iris prolapse, a wound leak, a flat anterior chamber, excessive corneal edema, or intraocular hemorrhage.

• Continue other systemic medications, including antiplatelets and anticoagulants, on the day of surgery and afterward unless the surgeon specifically advises otherwise.
• For diabetes: insulin and insulin secretagogues (sulfonylureas, meglitinides) may need a modified or held dose the day before or day of surgery because of hypoglycemia risk in the perioperative fasting state; metformin is often held the day before and day of surgery because of lactic acidosis risk — confirm any changes with the prescriber before surgery, and increase glucose monitoring frequency if doses are adjusted.
• Use a protective eye shield at night for the first week, or as directed, to prevent inadvertent rubbing or pressure on the eye during sleep.
• Avoid rubbing the operated eye.
• Avoid swimming, hot tubs, and dusty or dirty environments for the period the surgeon specifies.
• Avoid eye makeup on the operated eye until cleared by the surgeon.
• Avoid heavy lifting, straining, or bending at the waist in the first week, and avoid strenuous exercise until cleared.
• Driving: do not drive on the day of surgery, especially with a dilated pupil and blurred vision, and do not resume driving until vision meets the legal standard in both the operated and non-operated eye and the patient feels visually comfortable doing so.
• Dispose of any unused ophthalmic medication once the prescribed course is finished — these are limited-course products, and reusing a partly used bottle for a future, unrelated eye problem risks contamination or self-treating the wrong diagnosis.

Correct eye drop technique and sequencing when multiple drops are used

• Wash hands before each dose, and avoid letting the dropper tip touch the eye, eyelid, or any surface.
• When more than one eye drop is prescribed, separate the administration of each by at least 5 minutes — instilling drops too close together washes out the first drop before it can be absorbed.
• A practical order when the regimen includes a suspension (for example, prednisolone acetate) is to instill solutions before suspensions, since a suspension left on the ocular surface can slow absorption of a solution instilled afterward — confirm the specific order with the surgeon or pharmacist if uncertain.
• After instilling a drop, gently closing the eye for 30-60 seconds helps maximize ophthalmic absorption; for a medication where reducing systemic absorption matters, applying gentle pressure over the inner corner of the eye (nasolacrimal or punctal occlusion) for 30-60 seconds while keeping the eye closed reduces drainage of the drop into the nose and throat, where it can be absorbed systemically.
• Shake suspension formulations, such as prednisolone acetate, well before each use; solutions do not need shaking.

Pregnancy

Elective cataract surgery is uncommon in pregnancy and is typically deferred where possible, but urgent cases can occur. Topical ophthalmic antibiotics, corticosteroids, and NSAIDs are generally used with the same caution principles as other topical ophthalmic drugs in pregnancy — systemic absorption is low, but a topical NSAID should be used only when necessary given the known risks of oral NSAIDs later in pregnancy, and prolonged or high-dose topical corticosteroid use should be avoided where a reasonable alternative exists. Any decision to proceed with surgery and its drug regimen during pregnancy should directly involve the surgeon and the patient's obstetric provider.

Breastfeeding

Systemic absorption from topical ophthalmic antibiotics, corticosteroids, and NSAIDs is low, and standard postoperative regimens are generally considered compatible with breastfeeding; oral acetaminophen for postoperative analgesia is also compatible.

Pediatrics

Pediatric cataract surgery carries considerations beyond this chapter's adult-focused scope — amblyopia risk from visual deprivation, more pronounced postoperative inflammation, and a higher rate of steroid-induced IOP elevation than in adults — and is managed by pediatric ophthalmology with individualized dosing and monitoring.

Renal and hepatic impairment

Topical ophthalmic drops have minimal systemic absorption and generally do not require renal or hepatic dose adjustment. If oral acetazolamide is used for a severe pressure spike, check renal function given the risk of metabolic acidosis and electrolyte disturbance; if oral ciprofloxacin is used, for example after a ruptured lens capsule, renal dose adjustment applies as it would for any systemic use.

Follow the surgeon's specific visit schedule — typically postoperative day 1, about 1 week, and about 4 weeks, with additional visits if a higher-risk feature or complication is present. At every pharmacy contact, including a refill or a phone call, confirm the patient is applying each drop correctly and on schedule, with adequate spacing between different drops, and reinforce that the corticosteroid taper must be completed and never stopped abruptly. Ask specifically about pain, redness, and the trend in vision (better, the same, or worse) at every contact — a red-flag answer should trigger the same urgent-referral pathway described above rather than being deferred to the next scheduled visit. Confirm intraocular pressure has been checked if a corticosteroid course is being extended, since steroid-induced IOP elevation can develop silently over weeks. In a higher-risk patient, confirm that a dilated macular assessment or OCT has been arranged if the NSAID/corticosteroid course is being extended for suspected CME.

1. Persistent inflammation despite the standard taper: before escalating therapy, confirm the patient is actually using the drops correctly and on schedule — incorrect technique or missed doses is a more common explanation than true treatment failure.
2. Rebound inflammation after the corticosteroid is stopped or tapered too quickly: resume the corticosteroid and extend the taper over a longer period rather than stopping again at the same pace.
3. Intraocular pressure rises on the corticosteroid (a steroid response): consider switching to a lower-IOP-impact corticosteroid (loteprednol or fluorometholone) and/or adding a topical IOP-lowering agent; do not simply stop the corticosteroid abruptly while inflammation is still active, since this can trigger rebound.
4. Suspected cystoid macular edema — vision plateaus or declines around 4-6 weeks postoperatively, painless: refer for a dilated exam/OCT to confirm, extend or add the topical NSAID, and extend the corticosteroid taper; more refractory cases may need periocular or intravitreal corticosteroid under ophthalmology direction.
5. Any suspicion of infection at any point in this sequence: stop working through this list and refer immediately — endophthalmitis is not managed by adjusting the standard taper.
6. Confirmed nonadherence as the underlying issue: simplify the regimen where possible, for example a fixed antibiotic/corticosteroid combination product instead of 2 separate bottles, and discuss whether a dropless/sustained-release approach would suit a future fellow-eye surgery.

• Stopping the corticosteroid taper abruptly, or as soon as the eye feels comfortable, instead of completing the prescribed taper — this risks rebound inflammation.
• Instilling multiple eye drops back to back without at least 5 minutes of spacing, which washes out the first drop before it is absorbed.
• Mistaking normal early dysphotopsia (glare or a peripheral shadow) for a medication problem and stopping a needed drop, or conversely dismissing a genuinely progressive visual field defect as routine dysphotopsia.
• Managing reported eye pain with reassurance and analgesics instead of recognizing it as a potential red flag — significant postoperative pain is not expected and should prompt referral, not just acetaminophen.
• Discontinuing a patient's antiplatelet or anticoagulant around cataract surgery without confirming this was actually directed by the surgeon — these are usually continued.
• Missing the need to adjust diabetic medications, particularly metformin and insulin secretagogues, around the day of surgery because of the perioperative fasting state.
• Reusing a partly finished ophthalmic bottle left over from this surgery for a new, unrelated eye complaint later — these are limited-course products, and reuse risks contamination.
• Assuming a fourth-generation topical fluoroquinolone alone fully prevents endophthalmitis and downplaying red-flag symptoms because a topical antibiotic is already being used.

How to use this table: doses are adult doses and require patient-specific confirmation. A null link means no distinct monograph for that specific ophthalmic formulation exists yet in the Pharmasist Drug Database — where a monograph for the same molecule in a different formulation (oral, injectable) exists, it is deliberately not linked here to avoid misrepresenting the product. Select any linked drug name to open its complete Pharmasist Drug Database page.

Some surgeons additionally give an antibiotic by intracameral injection into the anterior chamber at the end of surgery (commonly moxifloxacin or cefuroxime, compounded or specially prepared for this route) rather than relying on topical drops alone — this is a one-time intraoperative step performed by the surgical team, not a postoperative self-administered medication, so it does not appear as its own row below.

Antibacterials — perioperative prophylaxis

A fourth-generation fluoroquinolone (moxifloxacin, besifloxacin) is the most commonly used topical choice; gatifloxacin and ofloxacin remain effective alternatives but are less commonly prescribed than moxifloxacin in current practice.

Glaucoma / intraocular pressure medications

Used short-term for a postoperative pressure spike. A patient already using a topical prostaglandin analogue or other glaucoma medication for pre-existing glaucoma should generally continue that regimen through the perioperative period unless the surgeon advises otherwise.

Anti-inflammatory agents — corticosteroids

Started the day after surgery and tapered over about 3-4 weeks in a standard-risk patient; continued longer with evidence of cystoid macular edema.

Anti-inflammatory agents — NSAIDs

Reduces the risk of cystoid macular edema without the IOP-elevation risk of a corticosteroid. Avoid all agents in this class in ASA/NSAID hypersensitivity or active asthma.

Dilators and cycloplegics

Used to keep the iris away from the intraocular lens implant during early healing and to improve comfort by reducing ciliary muscle spasm; less commonly needed with modern small-incision cataract surgery than with older techniques.

Oral analgesia